sglt2 inhibitors vs glp-1 agonists Blood Pressure-Lowering Effects of and Receptor https://link.springer.com/article/10.1007/s11906-025-01342-7 SGLT-2 Inhibitors and GLP-1 Agonists:
Description
K.SzboszlaiJ.GygiS

Changes of meibomian glands in patients with type 2 diabetes mellitus

DPP-4 inhibitors are simple to incorporate into existing therapy following metformin SU failure and are generally weight-neutral with few gastrointestinal side effects

Pipeline drugs like Vikings VK2735 and Amgens AMG 133 could raise the bar further by innovating on both biology and delivery, such as new receptor targeting strategies, novel molecular designs, and more patient-friendly dosing schedules

Do I add different medications

[32] Lim GE, et al
